Dr. Tracey Petryshen, Ph.D., scientific advisor
Dr. Tracey Petryshen is an Associate Professor of Psychiatry at Harvard Medical School and an Associate Member of the Broad Institute of MIT and Harvard in the United States. She obtained her Ph.D. degree in Medical Sciences (Medical Genetics) at the University of Calgary in Canada in 2001 for research on the genetic basis of dyslexia using family linkage and association methods. From 2001-2005, she carried out postdoctoral research training in psychiatric genetics with Dr. Pamela Sklar at the Broad Institute of MIT and Harvard. During that time, her research focused on schizophrenia and bipolar disorder using genetic association and postmortem brain gene expression approaches, as well as mouse quantitative trait locus (QTL) mapping of psychiatric intermediate phenotypes. In 2005, she was appointed an Instructor of Psychiatry at Harvard Medical School and she established a research laboratory in the Center for Human Genetic Research at Massachusetts General Hospital in Boston. In 2009, she was promoted to Assistant Professor of Psychiatry and in June 2015 to Associate Professor. From 2007-2012, Dr. Petryshen directed the Behavioral Neurogenetics Program in the Stanley Center for Psychiatric Research at the Broad Institute while also maintaining her academic laboratory at Massachusetts General Hospital. Dr. Petryshen’s research focuses on the genetic basis and treatment of major psychiatric disorders including schizophrenia, bipolar disorder, depression, and compulsive disorders. She is specifically interested in understanding how genetic changes perturb brain function and manifest as behavioral and cognitive abnormalities, and how these abnormalities can in turn be attenuated by clinical medications and novel small molecules targeting biochemical and epigenetic mechanisms implicated in psychiatric illness. Her laboratory utilizes human populations and animal and cellular model systems in combination with genetic association, behavioral neuroscience and pharmacology, biochemistry, and bioinformatics approaches.
1. del Re E, Bergen SE, Mesholam-Gately RI, Niznikiewicz M, Goldstein JM, Woo TU, Shenton ME, Seidman LJ, McCarley RW, Petryshen TL. Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds. Transl Psychiatry 4:3346, 2014.
2. Schroeder FA, Lewis MC, Fass DM, Wagner FF, Zhang Y-L, Hennig KM, Gale J, Zhao W-N, Reis S, Barker DD, Berry-Scott E, Kim SW, Clore EL, Hooker JM, Holson EB, Haggarty SJ, Petryshen TL. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests. PLOS ONE 8:e71323, 2013.
3. Leussis MP, Berry-Scott EM, Saito M, Jhuang H, de Haan G. Alkan O, Luce CJ, Madison JM, Sklar P, Serre T, Root DE, Petryshen TL. The ankyrin 3 (ANK3) bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry 73:683-90, 2013.
4. Pan JQ*, Lewis MC*, Ketterman JK, Clore EL, Riley M, Richards K, Berry-Scott E, Liu X, Wagner FF, Holson EB, Neve RL, Biechele TL, Moon RT, Scolnick EM, Petryshen TL, Haggarty SJ. (joint corresponding author) AKT Kinase Activity is Required for Lithium to Modulate Mood-Related Behaviors in Mice. Neuropsychopharmacology 36:1397-411, 2011. *equal contribution
5. Petryshen TL, Sabeti PC, Aldinger KA, Fry B, Fan JB, Schaffner SF, Waggoner SG, Tahl AR, Sklar P. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15:810-5, 2010.
6. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, Morley CP, McGann L, Gentile KL, Rockwell GN, Medeiros HM, Carvalho C, Macedo A, Dourado A, Valente J, Ferreira CP, Patterson NJ, Azevedo MH, Daly MJ, Pato CN, Pato MT, Sklar P. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10:366-374, 2005.
7. Petryshen TL, Middleton FA, Tahl AR, Rockwell GN, Purcell S, Aldinger KA, Kirby A, Morley CP, McGann L, Gentile KL, Waggoner SG, Medeiros HM, Carvalho C, Macedo A, Albus M, Maier W, Trixler M, Eichhammer P, Schwab SG, Wildenauer DB, Azevedo MH, Pato MT, Pato CN, Daly MJ, Sklar P. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry 10(12):1074-1088, 2005.
Prof. Dr. Wiebe Kruijer, Ph.D., scientific advisor
Wiebe Kruijer (1951) studied Chemistry/Biochemistry and Pharmacy at the University of Groningen, The Netherlands, where he graduated in 1978. He obtained his Ph.D. degree in Physiological Chemistry (nucleotide sequence analysis of wild-type and mutant genes encoding adenovirus DNA binding protein) in 1983 at the University of Utrecht, The Netherlands. He then worked as a (senior) Research Associate at the Molecular Biology and Virology Laboratory, The Salk Institute for Biological Studies, San Diego, USA (1983-1985) and at the Hubrecht Laboratory, Netherlands Institute of Developmental Biology (NIOB) of the Royal Academy of Arts and Sciences, Utrecht (1985-1993). From 1993 to 2006, he was Professor of Developmental Genetics at the Department of Biology, Faculty of Mathematics and Natural Sciences, University of Groningen. From 2003 until present, he was Professor and continues as Emeritus Professor in Molecular Cell Biology, Faculty of Science and Technology, University of Twente, The Netherlands.